(UPDATED) In stable CAD patients, using intravascular lithotripsy to break up superficial or deep calcium and pave the way for stent implantation results in good outcomes to 1 year, with low rates of ...
(UPDATED) Coronary intravascular lithotripsy shows promise for improving the ability to optimize PCI in severely calcified lesions, with good safety and efficacy out to 30 days, according to data from ...
Coronary Artery Disease (CAD) is the most common heart disease and most frequent cause of death in the U.S., with over 20 million adults affected by this condition Abbott's investigational Coronary ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — An intravascular lithotripsy device used for vessel preparation for stenting in patients with ...
Please provide your email address to receive an email when new articles are posted on . Shockwave Medical announced its intravascular lithotripsy system received premarket approval from the FDA for ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed, investigational system that aims to fracture hardened calcium within the ...
What is Lithotripsy or Extracorporeal Shock Wave Lithotripsy (ESWL)? Lithotripsy is a process that uses acoustic or high intensity sound waves (called shock waves) to break stones in the kidney, ...
Abbott announced that the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to evaluate the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results